Cargando…

Baseline VDJ clonotype detection using a targeted sequencing NGS assay: allowing for subsequent MRD assessment

Detalles Bibliográficos
Autores principales:	Hultcrantz, Malin, Rustad, Even Holth, Yellapantula, Venkata, Arcila, Maria, Ho, Caleb, Syed, Mustafa H., Papaemmanuil, Elli, Zhang, Yanming, Maura, Francesco, Landgren, Ola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376205/ https://www.ncbi.nlm.nih.gov/pubmed/32699232 http://dx.doi.org/10.1038/s41408-020-00343-w

Ejemplares similares

Baseline identification of clonal V(D)J sequences for DNA-based minimal residual disease detection in multiple myeloma
por: Rustad, Even H., et al.
Publicado: (2019)

Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients
por: Kazandjian, Dickran, et al.
Publicado: (2019)

Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma
por: Yellapantula, Venkata, et al.
Publicado: (2019)

Correction: Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma
por: Yellapantula, Venkata, et al.
Publicado: (2020)

Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma
por: Maclachlan, Kylee H., et al.
Publicado: (2021)

NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on an MRD-based protocol
por: Svaton, Michael, et al.
Publicado: (2023)

Clonotype definitions for immunogenetic studies: proposals from the EuroClonality NGS Working Group
por: Sofou, Electra, et al.
Publicado: (2023)

IMGT/StatClonotype for Pairwise Evaluation and Visualization of NGS IG and TR IMGT Clonotype (AA) Diversity or Expression from IMGT/HighV-QUEST
por: Aouinti, Safa, et al.
Publicado: (2016)

Comparison of NGS and MFC Methods: Key Metrics in Multiple Myeloma MRD Assessment
por: Kriegsmann, Katharina, et al.
Publicado: (2020)

Role of MRD status in relation to clinical outcomes in newly diagnosed multiple myeloma patients: a meta-analysis
por: Landgren, Ola, et al.
Publicado: (2016)

Vidjil add‐on for MRD quantification of samples processed using the EuroClonality‐NGS protocol
por: Giusti, Guilherme Navarro Nilo, et al.
Publicado: (2023)

Waldenström macroglobulinemia whole genome reveals prolonged germinal center activity and late copy number aberrations
por: Maclachlan, Kylee H., et al.
Publicado: (2022)

Timing the initiation of multiple myeloma
por: Rustad, Even H., et al.
Publicado: (2020)

The dynamics of immunoglobulin V-gene usage and clonotype expansion in mice after prime and boost immunizations as analyzed by NGS
por: Farfán-Arribas, Diego J., et al.
Publicado: (2017)

Tailored treatment to MRD response: A phase I/II study for newly diagnosed multiple myeloma patients using high dose twice‐weekly carfilzomib (45 and 56 mg/m(2)) in combination with lenalidomide and dexamethasone
por: Korde, Neha, et al.
Publicado: (2021)

mmsig: a fitting approach to accurately identify somatic mutational signatures in hematological malignancies
por: Rustad, Even H., et al.
Publicado: (2021)

VDJ Recombination: Artemis and Its In Vivo Role in Hairpin Opening
por: Mansilla-Soto, Jorge, et al.
Publicado: (2003)

Individualized VDJ recombination predisposes the available Ig sequence space
por: Slabodkin, Andrei, et al.
Publicado: (2021)

Immunophenotypic correlates of sustained MRD negativity in patients with multiple myeloma
por: Coffey, David G., et al.
Publicado: (2023)

T-cell clonotypes in cancer
por: thor Straten, Per, et al.
Publicado: (2004)

Advantages and Challenges of Using ctDNA NGS to Assess the Presence of Minimal Residual Disease (MRD) in Solid Tumors
por: Larribère, Lionel, et al.
Publicado: (2021)

Pretransplant FLT3-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcome
por: Loo, Sun, et al.
Publicado: (2022)

Tumor suppressor CD99 is downregulated in plasma cell neoplasms lacking CCND1 translocation and distinguishes neoplastic from normal plasma cells and B cell lymphomas with plasmacytic differentiation from primary plasma cell neoplasms
por: Gao, Qi, et al.
Publicado: (2018)

VDJ Gene Usage in IgM Repertoires of Rhesus and Cynomolgus Macaques
por: Chernyshev, Mark, et al.
Publicado: (2022)

Accelerated single cell seeding in relapsed multiple myeloma
por: Landau, Heather J., et al.
Publicado: (2020)

Author Correction: Accelerated single cell seeding in relapsed multiple myeloma
por: Landau, Heather J., et al.
Publicado: (2021)

P1263: A SENSITIVE NGS ASSAY TO DETECT MEASURABLE RESIDUAL DISEASE (MRD) IN B-CELL LYMPHOPROLIFERATIVE DISEASES
por: Hebert, L., et al.
Publicado: (2022)

NGS-defined measurable residual disease (MRD) after initial chemotherapy as a prognostic biomarker for acute myeloid leukemia
por: Li, Yonghong, et al.
Publicado: (2023)

PB1781: THE APPLICATION OF CF-DNA FOR NGS MRD STUDIES IN PATIENTS WITH LMA IMPROVES THE SENSITIVITY OF THE METHOD WITH RESPECT TO CTC.
por: Sánchez-Redondo, Noemí Álvarez, et al.
Publicado: (2023)

Developmental Regulation of VDJ Recombination By the Core Fragment of the T Cell Receptor α Enhancer
por: Roberts, Joseph L., et al.
Publicado: (1997)

Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
por: Medina, Alejandro, et al.
Publicado: (2020)

Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities
por: Oben, Bénedith, et al.
Publicado: (2021)

A clonotype nomenclature for T cell receptors
por: Yassai, Maryam B., et al.
Publicado: (2009)

Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing: Feasibility, Challenges, and Direct Comparison with High-Sensitivity Flow Cytometry
por: Ho, Caleb, et al.
Publicado: (2021)

Consistency of VDJ Rearrangement and Substitution Parameters Enables Accurate B Cell Receptor Sequence Annotation
por: Ralph, Duncan K., et al.
Publicado: (2016)

PDL1 Expression on Plasma and Dendritic Cells in Myeloma Bone Marrow Suggests Benefit of Targeted anti PD1-PDL1 Therapy
por: Sponaas, Anne-Marit, et al.
Publicado: (2015)

SURROGATE SELECTION OVERSAMPLES EXPANDED T CELL CLONOTYPES
por: Yu, Peng, et al.
Publicado: (2023)

History of autoimmune disease is associated with impaired survival in multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study
por: Lindqvist, Ebba K., et al.
Publicado: (2016)

411 Mrd. €, 11,9 %
por: Kuhn, Joseph
Publicado: (2022)

PDK1 regulates VDJ recombination, cell-cycle exit and survival during B-cell development
por: Venigalla, Ram K C, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_c5djcoehlavhbg0tqh3n6624uo